Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate

Veterinary Microbiology

Volumn 144, Issue 1-2, 2010, Pages 67-74

  Kyriakis, C S ^a   Gramer, M R ^b   Barbe F ^a   Van Doorsselaere, J ^c   Van Reeth, K ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Department of Health Care and Biotechnology   (Belgium)

Author keywords

Antigenic drift; Efficacy; H1N1 swine influenza virus; Pigs; Vaccines

Indexed keywords

GRIPOVAC; HEMAGGLUTININ; RESPIPORC; SUVAXYN; SWINE INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HEMAGGLUTINATION INHIBITION TEST; IMMUNOGENICITY; INFLUENZA VIRUS A H1N1; NONHUMAN; PROVOCATION TEST; SEQUENCE HOMOLOGY; SWINE; VACCINATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, VIRAL; EMULSIONS; EUROPE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININS, VIRAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; SWINE DISEASES; VACCINES, INACTIVATED;

SUIDAE; SWINE INFLUENZA VIRUS;

EID: 77954814729     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2009.12.039     Document Type: Article

References (32)

1. Altschul S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research 1997, 25:3389-3402.
2. Both G.W., Shi C.H., Kilbourne E.D. Hemagglutinin of swine influenza virus: a single amino acid change pleiotropically affects viral antigenicity and replication. Proceedings of the National Academy Sciences 1983, 80:6996-7000.
3. Brown I.H., Chakraverty P., Harris P.A., Alexander D.J. Disease outbreaks in pigs in Great Britain due to an influenza A virus of H1N2 subtype. Veterinary Record 1995, 136:328-329.
4. Brown I.H., Harris P.A., McCauley J.W., Alexander D.J. Multiple genetic reassortment of avian and human influenza A viruses in European pigs, resulting in the emergence of an H1N2 virus of novel genotype. Journal of General Virology 1998, 79:2947-2955.
5. Brown I.H The epidemiology and evolution of influenza viruses in pigs. Veterinary Microbiology 2000, 74:29-46.
6. Campitelli L., Donatelli I., Foni E., Castrucci M.R., Fabiani C., Kawaoka Y., Krauss S., Webster R.G. Continued evolution of H1N1 and H3N2 influenza viruses in pigs in Italy. Virology 1997, 232:310-318.
7. Caton A.J., Brownlee G.G., Yewdell J.W., Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982, 31:417-427.
8. Cooper J. Batch safety testing of veterinary vaccines-potential welfare implications of injection volumes. Alternative Laboratory Animals 2008, 36:685-694.
9. de Jong J.C., Heinen P.P., Loeffen W.L.A., van Nieuwstadt A.P., Claas E.C.J., Besebroer T.M., Bijsma K., Verweji C., Osterhaus A.D.M.E., Rimmelzwaan G.F., Fouchier R.A.M., Kimman T.G. Antigenic and molecular heterogeneity in recent swine influenza A (H1N1) virus isolates with possible implications for vaccination policy. Vaccine 2001, 19:4452-4464.
10. de Jong J.C., Smith D.J., Lapedes A.S., Donatelli I., Campitelli L., Barigazzi G., Van Reeth K., Jones T.C., Rimmelzwaan G.F., Osterhaus A.D., Fouchier R.A. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. Journal of Virology 2001, 81:4315-4322.
11. Dürrwald R. Development of a trivalent swine influenza A virus vaccine with high potency against the newly emerged subtype H1N2 comprising up-to-date H1N1, H3N2 and H1N2 vaccine strains. Proceedings of the 5th International Symposium on Emerging and Re-emerging Pig Diseases 2007, 235.
12. Dyce K.M., Sack W.O., Wensing C.J.G. The Vertebral Column, Back and Thorax of the Pig. Textbook of Veterinary Anatomy 2002, Elsevier Science, pp. 772-775. 3rd edition.
13. Eichelberger M., Golding H., Hess M., Weir J., Subbarao K., Luke C.J., Friede M., Wood D. A/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2007, 34:4299-4303.
14. European Pharmacopoeia, 2004. Porcine influenza vaccine (inactivated). European Pharmacopoeia 5.0 Volume 1, pp. 785-787.
15. Genbank website: http://www.ncbi.nlm.nih.gov/Genbank/index.html.
16. Haesebrouck F., Pensaert M.B. Effect of intratracheal challenge of fattening pigs previously immunised with an inactivated influenza H1N1 vaccine. Veterinary Microbiology 1986, 11:239-249.
17. Olsen C.W., Brown I., Easterday B.C., Van Reeth K. Swine influenza. Diseases of Swine 2006, 469-482. Iowa State University Press. 9th edition. B.E. Straw, J.J. Zimmerman, S. D'Allaire, D.J. Taylor (Eds.).
18. Palmer D.F., Coleman M.T., Dowdle W.R., Schild G.C. Advanced Laboratory Techniques for Influenza Diagnosis 1975, US Department of Health, Education and Welfare Immunology No 6.
19. Pensaert M., Ottis K., Vandeputte J., Kaplan M.M., Bachmann P.A. Evidence for the natural transmission of influenza A virus from wild ducks to swine and its potential importance for man. Bulletin of the World Health Organization 1981, 59:75-78.
20. Reed L.J., Münch H. A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 1938, 27:493-497.
21. Rimmelzwaan G.F., de Jong J.C., Bestebroer T.M., van Loon A.M., Claas E.C., Fouchier R.A., Osterhaus A.D. Antigenic and genetic characterization of swine influenza A (H1N1) viruses isolated from pneumonia patients in The Netherlands. Virology 2001, 282:301-306.
22. Swayne D.E., Perdue M.L., Beck J.R., Garcia M., Suarez D.L. Vaccines protect chickens against H5 highly pathogenic avian influenza viruses in the face of genetic changes in field viruses over multiple years. Veterinary Microbiology 2000, 74:165-172.
23. Swayne D.E., Lee C.-W., Spackman E. Inactivated North-American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 highly pathogenicity avian influenza virus. Avian Pathology 2009, 35:141-146.
24. Van Reeth K., Brown I.H., Pensaert M. Isolations of H1N2 influenza A virus from pigs in Belgium. Veterinary Record 2000, 146:588-589.
25. Van Reeth K., Labarque G., De Clercq S., Pensaert M. Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection. Vaccine 2001, 19:4479-4486.
26. Van Reeth K., Gregory V., Hay A., Pensaert M. Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes. Vaccine 2003, 21:1375-1381.
27. Van Reeth K., Van Gucht S., Pensaert M. Investigations of the efficacy of European H1N1- and H3N2-based swine influenza vaccines against the novel H1N2 subtype. Veterinary Record 2003, 153:9-13.
28. Van Reeth K., Brown I., Essen S., Pensaert M. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs. Virus Research 2004, 103:115-124.
29. Van Reeth K., Brown I.H., Dürrwald R., Foni E., Labarque G., Lenihan P., Maldonado J., Markowska-Daniel I., Pensaert M., Pospisil Z., Koch G. Seroprevalence of H1N1, H3N2 and H1N2 influenza viruses in pigs in seven European countries in 2002-2003. Influenza and Other Respiratory Viruses 2008, 2:99-105.
30. Vincent A.L., Ma W., Lager K.L., Gramer M.R., Richt J.A., Janke B.H. Characterization of a newly emerged genetic cluster of H1N1 and H1N2 swine influenza virus in the United States. Virus Genes 2009, 39:176-185.
31. Webster R.G., Thomas T.L. Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)-a new equine influenza virus. Vaccine 1993, 11:987-993.
32. Zell R., Motzke S., Krumbholz A., Wutzler P., Herwig V., Dürrwald R. Novel reassortant of swine influenza H1N2 virus in Germany. Journal of General Virology 2008, 89:271-276.